For instance, Liu et al. reported that Fuzheng Xiaozheng Prescription (FZXZP) exhibit satisfactory therapeutic effects in cirrhosis and hepatocellular carcinoma (HCC) treatments by activating PPAR signaling pathway [107]. The gene discussed is PPARA; the disease is hepatocellular carcinoma.